Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is a publicly traded Healthcare sector company. As of May 21, 2026, TARS trades at $64.83 with a market cap of $2.70B and a P/E ratio of -56.22. TARS moved +5.71% today. Year to date, TARS is -18.76%; over the trailing twelve months it is +44.36%. Its 52-week range spans $31.36 to $85.25. Analyst consensus is strong buy with an average price target of $95.17. Rallies surfaces TARS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TARS moved +5.71% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $64.83 |
| Market Cap | $2.70B |
| P/E Ratio | -56.22 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.25 |
| 52-Week Low | $31.36 |
| Volume | 433.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $535.08M |
| Net Income | $-48.27M |
| Gross Margin | 0.00% |
8 analysts cover TARS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $95.17.